文献速递银屑病与炎症性皮肤病

IL-22受体非经典STAT3激活促进银屑病样皮炎

A Targetable, Noncanonical Signal Transducer and Activator of Transcription 3 Activation Induced by the Y-Less Region of IL-22 Receptor Orchestrates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice.
PubMed 文献 · J Invest Dermatol · 2021-05-14

该研究在小鼠中探讨IL-22受体α亚基C端无Y区域介导的非经典STAT3激活在咪喹莫特诱导的银屑病样皮炎中的作用。表达C端截短IL-22Rα的小鼠对银屑病样皮炎有一定保护,但程度弱于Il22ra-/-小鼠;而只有Il22ra-/-小鼠在柠檬酸杆菌感染后出现体重下降。提示靶向该非经典通路可能治疗银屑病样炎症而不影响肠道屏障防御。

要点

  • IL-22Rα的C端无Y区域介导非经典STAT3激活。
  • 截短该区域可部分减轻咪喹莫特诱导的小鼠银屑病样皮炎。
  • 完全敲除IL-22Rα才影响肠道抗感染防御,提示靶向非经典通路安全性可能更好。

核心结论

  • 特异性抑制IL-22Rα无Y区域介导的非经典STAT3激活可能治疗银屑病样皮肤炎症,而不影响IL-22依赖的肠道组织修复或屏障防御。

研究设计与样本

  • 小鼠实验研究:比较表达C端截短IL-22Rα的ΔCtermut/mut小鼠与Il22ra-/-小鼠在咪喹莫特诱导银屑病样皮炎模型及柠檬酸杆菌感染模型中的表现。

主要发现

  • ΔCtermut/mut小鼠对咪喹莫特诱导的银屑病样皮炎病变有保护作用,但保护程度弱于Il22ra-/-小鼠。
  • 柠檬酸杆菌感染后,仅Il22ra-/-小鼠出现体重下降,ΔCtermut/mut小鼠未出现。

临床怎么用

  • 提示靶向IL-22Rα非经典STAT3激活通路可能作为银屑病治疗策略,且可能避免影响肠道屏障防御。

局限性

  • 研究为小鼠模型,结论需进一步在人体中验证。
  • 未报告具体样本量、统计数值等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Exacerbated IL-22 activity induces tissue inflammation and immune disorders such as psoriasis. However, because IL-22 is also essential for tissue repair and defense at barrier interfaces, targeting IL-22 activity to treat psoriasis bears the risk of deleterious effects at mucosal sites such as the gut. We previously showed in vitro that IL-22 signaling relies on IL-22 receptor alpha (IL-22Rα) Y-dependent and -independent pathways. The second depends on the C-terminal Y-less region of IL-22Rα and leads to a massive signal transducer and activator of transcription 3 (STAT3) activation. Because STAT3 activation is associated with the development of psoriasis, we hypothesized that the specific inhibition of the noncanonical STAT3 activation by the Y-less region of IL-22Rα could reduce psoriasis-like disease while leaving intact its tissue defense functions in the gut. We show that mice expressing a C-terminally truncated version of IL-22Rα (ΔCtermut/mut mice) are protected from the development of psoriasis-like dermatitis lesions induced by imiquimod to a lesser extent than Il22ra-/- mice. In contrast, only Il22ra-/- mice lose weight after Citrobacter rodentium infection. Altogether, our data suggest that specific targeting of the noncanonical STAT3 activation by IL-22 could serve to treat psoriasis-like skin inflammation without affecting IL-22‒dependent tissue repair or barrier defense at other sites.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Michiels C, Puigdevall L, Cochez P, et al. A Targetable, Noncanonical Signal Transducer and Activator of Transcription 3 Activation Induced by the Y-Less Region of IL-22 Receptor Orchestrates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. J Invest Dermatol. 2021. PMID: 33992648. doi:10.1016/j.jid.2021.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。